Compugen Ltd. (NASDAQ:CGEN) Short Interest Down 32.6% in August - MarketBeat
Yesterday • Google News
Compugen (CGEN)
US$ 00%
Price Chart
Key Statistics
Market Cap
$ 129.55M
P/E Ratio
0.00
Revenue (TTM)
$ 22.14M
Volume
0
52W High
$ 2.66
52W Low
$ 1.13
Dividend Yield
0.00%
Beta
2.59
Technicals
50-Day MA
1.4984
200-Day MA
1.6402
52 Week High
2.66
52 Week Low
1.13
About CGEN
Compugen Ltd., a clinical-stage therapeutic discovery and development company, engages in the research, development, and commercialization of therapeutics and product candidates in Israel, the United .
Employees
74
Headquarters
Holon, Israel
CEO
Dr. Anat Cohen-Dayag Ph.D.